规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
产品名称 | MEK ↓ ↑ | MEK1 ↓ ↑ | MEK1/2 ↓ ↑ | MEK2 ↓ ↑ | MEK5 ↓ ↑ | 其他靶点 | 纯度 | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Honokiol | ✔ | 98% | |||||||||||||||||
Mirdametinib |
++++
MEK, IC50: 0.33 nM |
99%+ | |||||||||||||||||
Binimetinib |
+++
MEK, IC50: 12 nM |
99%+ | |||||||||||||||||
BI-847325 |
++
MEK1, IC50: 25 nM |
+++
MEK2, IC50: 4 nM |
99%+ | ||||||||||||||||
U0126-EtOH |
+
MEK1, IC50: 0.07 μM |
++
MEK2, IC50: 0.06 μM |
98% | ||||||||||||||||
GDC-0623 |
++++
MEK1, IC50: 0.13 nM |
99%+ | |||||||||||||||||
TAK-733 |
++++
MEK1, IC50: 3.2 nM |
99%+ | |||||||||||||||||
Trametinib |
++++
MEK1, IC50: 0.92 nM |
++++
MEK2, IC50: 1.8 nM |
99%+ | ||||||||||||||||
Selumetinib |
+++
MEK1, IC50: 14 nM MEK1, Kd: 99 nM |
+
MEK2, Kd: 530 nM |
99%+ | ||||||||||||||||
CI-1040 |
++
MEK1, IC50: 17 nM |
++
MEK2, IC50: 17 nM |
99%+ | ||||||||||||||||
Myricetin | ✔ | 98% | |||||||||||||||||
Refametinib |
++
MEK1, IC50: 19 nM |
++
MEK2, IC50: 47 nM |
99%+ | ||||||||||||||||
Cobimetinib |
+++
MEK1, IC50: 4.2 nM |
99%+ | |||||||||||||||||
PD98059 |
+
MEK1, IC50: 2 μM |
99%+ | |||||||||||||||||
SL327 |
+
MEK1, IC50: 0.18 μM |
+
MEK2, IC50: 0.22 μM |
AP-1 | 98+% | |||||||||||||||
PD318088 | ✔ | 99% | |||||||||||||||||
AZD8330 |
+++
MEK1/2, IC50: 7 nM |
99%+ | |||||||||||||||||
Pimasertib | 98% | ||||||||||||||||||
(E/Z)-BIX02189 |
++++
MEK5, IC50: 1.5 nM |
99%+ | |||||||||||||||||
(E/Z)-BIX02188 |
+++
MEK5, IC50: 4.3 nM |
99% | |||||||||||||||||
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 |
靶点 |
|
描述 | NQDI-1 inhibits apoptosis signal-regulating kinase 1 (ASK1) with a Ki of 500 nM. |
Concentration | Treated Time | Description | References | |
BV-2 cells | 10 μM | 24 h | NQDI1 decreased the phosphorylation and expression of ASK1, reduced the phosphorylation of p-38 and JNK, decreased the activity and the expression of MMP-9, and inhibited IBA-1 expression. | J Neuroinflammation. 2023 Feb 3;20(1):22. |
SKOV3 cells | 10 μM | 24 h | Inhibition of ASK1 expression, reduction of total Noxa protein and mitochondrial localization, and increase in Bcl-2 expression, thereby attenuating low glucose and metformin-induced apoptosis | J Exp Clin Cancer Res. 2019 Feb 13;38(1):77. |
mouse embryonic fibroblasts (MEFs) | 10 μM, 30 μM, 50 μM | 24 h | To determine the inhibitory effect of NQDI-1 on ASK1 phosphorylation, results showed that 10 μM NQDI-1 reduced ASK1 phosphorylation to 40% of control, 30 μM almost completely inhibited, and 50 μM completely inhibited ASK1, JNK, and p38 phosphorylation. | Cell Death Dis. 2014 Nov 13;5(11):e1522. |
Administration | Dosage | Frequency | Description | References | ||
Mice | Postoperative pain model | Intrathecal injection | 5 μg/10 μl | Once daily for 5 days | NQDI-1 decreased the phosphorylation of ASK1, p-38, and JNK, reduced the activity and expression of MMP-9, and attenuated postoperative pain. | J Neuroinflammation. 2023 Feb 3;20(1):22. |
Nude mice | Ovarian cancer xenograft model | Intraperitoneal injection | 1 mg/kg | Once daily until tumor volume reached 150-200 mm3 | To evaluate the inhibitory effect of NQDI-1 on the anti-tumor activity of metformin, it was found that NQDI-1 weakened the anti-tumor effect of metformin alone | J Exp Clin Cancer Res. 2019 Feb 13;38(1):77. |
Mice | Ectopic ossification model | Subcutaneous injection | 30 μM | Single injection, lasting 2 weeks | To evaluate the effect of NQDI-1 on ectopic ossification, results showed that 30 μM NQDI-1 increased bone volume by 64%, comparable to the 82% increase observed in ASK1 KO mice. | Cell Death Dis. 2014 Nov 13;5(11):e1522. |
Mice | Intracerebral hemorrhage model | Intracerebroventricular injection | 250 nM/mouse | Single dose 30 min before ICH induction | NQDI-1 alone improved neurological functions and down-regulated ASK1/JNK/p38 MAPK expression after ICH. | Br J Pharmacol. 2019 May;176(9):1341-1356 |
Mice | Liver ischemia/reperfusion injury model | Intraperitoneal injection | 10 mg/kg | Single injection, lasting until 6 hours after reperfusion | NQDI-1 alleviates liver ischemia/reperfusion injury by inhibiting the ASK1-JNK/P38 signaling pathway | Front Pharmacol. 2022 Sep 8;13:951906 |
计算器 | ||||
存储液制备 | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
3.13mL 0.63mL 0.31mL |
15.66mL 3.13mL 1.57mL |
31.32mL 6.26mL 3.13mL |
CAS号 | 175026-96-7 |
分子式 | C19H13NO4 |
分子量 | 319.31 |
SMILES Code | O=C(C1=C2C3=C(NC1=O)C=CC=C3C(C4=C2C=CC=C4)=O)OCC |
MDL No. | MFCD03265970 |
别名 | |
运输 | 蓝冰 |
InChI Key | UFJGFNHRMPMALC-UHFFFAOYSA-N |
Pubchem ID | 5522952 |
存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Sealed in dry, room temperature |
溶解方案 |
DMSO: 9 mg/mL(28.19 mM),配合低频超声,并水浴加热至45℃助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|